Cite
HARVARD Citation
Phillips, J. et al. (2020). Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine. European journal of gastroenterology & hepatology. 32 (10), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Phillips, J. et al. (2020). Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine. European journal of gastroenterology & hepatology. 32 (10), p. . [Online].